Medication and Counseling for Controlled Drinking (Project SMART)

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

February 28, 2010

Study Completion Date

June 30, 2010

Conditions
Alcohol-related DisordersAlcohol DrinkingAlcoholismAlcohol Abuse
Interventions
DRUG

Naltrexone

Naltrexone, 100 mg. oral dosage, daily for 12 weeks.

BEHAVIORAL

Modified Behavioral Self-Control Psychotherapy

Moderation- and cognitive-behaviorally-based psychotherapy. Treatment goal of moderation of alcohol consumption. 12 weekly, 1-hour sessions.

BEHAVIORAL

Brief Behavioral Compliance Enhancement Therapy

Brief supportive counseling to enhance compliance with medication and encourage goal-setting concerning alcohol consumption

Trial Locations (1)

10019

Research Foundation for Mental Hygiene, Columbia Addiction Services and Psychotherapy Intervention Research, 3 Columbus Circle, Suite 1404, New York

All Listed Sponsors
lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

NCT00444418 - Medication and Counseling for Controlled Drinking (Project SMART) | Biotech Hunter | Biotech Hunter